ShangPharma has begun operations at its new facility in Fengxian, China. The cGMP multi-purpose pharmaceutical development and manufacturing facility includes a pilot plant with reactor capacities ranging from 200L to 3000L as well as reactors for high temperature, cryogenics, highly toxic and pressurised reactions, including hydrogenation.
Seeking Alpha
Monday 17 January 2011
ShangPharma starts cGMP facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment